The Selective Estrogen Receptor Modulator 4-Hydroxy Tamoxifen Induces G1 Arrest and Apoptosis of Multiple Myeloma Cell Lines - Université de Tours Accéder directement au contenu
Article Dans Une Revue Annals of the New York Academy of Sciences Année : 2003

The Selective Estrogen Receptor Modulator 4-Hydroxy Tamoxifen Induces G1 Arrest and Apoptosis of Multiple Myeloma Cell Lines

Résumé

Multiple myeloma (MM) is an incurable hematological malignancy for which new therapeutic strategies should be envisaged. The selective estrogen receptor modulator (SERM), 4-hydroxy tamoxifen (4-OHTam), in the range of 1 to 10 micro M, was able to impair the cell proliferation of MM cell lines. This was achieved by blocking cells at the G1 phase of the cell cycle and by inducing apoptosis. This cellular response was observed in five out of six tested cell lines, all five expressing both alpha and beta estrogen receptor forms. No modifications of Bcl-2, Bcl-X, and Bax levels were observed, as well as no changes in Pi3K/Akt and JAK/STAT pathways that are often constitutively active in these cells. The signalization of 4-OHTam-induced cell death needs further investigation.
Fichier principal
Vignette du fichier
The selective estrogen receptor modulator 4-hydroxy tamoxifen induces G1 arrest and apoptosis of multiple myeloma cell lines.pdf (2.4 Mo) Télécharger le fichier
Origine : Accord explicite pour ce dépôt

Dates et versions

hal-02427345 , version 1 (03-11-2021)

Identifiants

Citer

Juliette Gauduchon, Fabrice Gouilleux, Sébastien Maillard, Véronique Marsaud, Michel Renoir, et al.. The Selective Estrogen Receptor Modulator 4-Hydroxy Tamoxifen Induces G1 Arrest and Apoptosis of Multiple Myeloma Cell Lines. Annals of the New York Academy of Sciences, 2003, 1010 (1), pp.321-325. ⟨10.1196/annals.1299.057⟩. ⟨hal-02427345⟩
35 Consultations
71 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More